ClinicalTrials.govpublic full text
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
peripheral t-cell lymphoma, not otherwise specified, angioimmunoblastic t-cell lymphoma, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830779
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.